M51 Osteoporosis Drug Holidays: Data and Opinions

Program: Meet-the-Professor Sessions
Clinical Session
Monday, April 4, 2016: 9:00 AM-9:45 AM
Room 253 (BCEC)
Speaker:
Nelson B Watts, MD, Mercy Health, Cincinnati, OH

Disclosures:
NBW: Advisory Group Member, Amgen, Speaker Bureau Member, Amgen, Advisory Group Member, Merck & Co., Scientific Board Member, Abbvie, Investigator, NPS, Ad Hoc Consultant, Sanofi.

Osteoporosis drug holidays to prevent atypical femoral fractures are widely implemented among practioners despite uncertainty regarding the effectiveness and/or harm of this strategy. A literature review and case based discussion will help bring attendees up to date on this controversial area.

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire